✦ LIBER ✦

Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab

✍ Scribed by B. G. Feagan; W. J. Sandborn; D. C. Wolf; G. Coteur; O. Purcaru; Y. Brabant; P. J. Rutgeerts

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful induction of clinical respons

✍ Silvio Danese; Filippo Mocciaro; Luisa Guidi; Maria Lia Scribano; Michele Comber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Clinical trial: the effects of certolizu

✍ B. G. FEAGAN; M. C. REILLY; L. GERLIER; Y. BRABANT; M. BROWN; S. SCHREIBER 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Certolizumab pegol, a monthly subcutaneo

✍ Paul Rutgeerts; Stefan Schreiber; Brian Feagan; Dorothy L. Keininger; Liz O’Neil 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 250 KB

Gene polymorphisms and serological marke

✍ B. R. Yacyshyn; A. Schievella; K. L. Sewell; J. A. Tami 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

The CHOICE trial: adalimumab demonstrate

✍ S. Lichtiger; D. G. Binion; D. C. Wolf; D. H. Present; A. G. Bensimon; E. Wu; A. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Efficacy and safety of short-term adalim

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB